These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 17938269)
1. Malignant mesothelioma cells are rapidly sensitized to TRAIL-induced apoptosis by low-dose anisomycin via Bim. Abayasiriwardana KS; Barbone D; Kim KU; Vivo C; Lee KK; Dansen TB; Hunt AE; Evan GI; Broaddus VC Mol Cancer Ther; 2007 Oct; 6(10):2766-76. PubMed ID: 17938269 [TBL] [Abstract][Full Text] [Related]
2. Ribotoxic stress sensitizes glioblastoma cells to death receptor induced apoptosis: requirements for c-Jun NH2-terminal kinase and Bim. Xia S; Li Y; Rosen EM; Laterra J Mol Cancer Res; 2007 Aug; 5(8):783-92. PubMed ID: 17699104 [TBL] [Abstract][Full Text] [Related]
3. Translation inhibitors sensitize prostate cancer cells to apoptosis induced by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) by activating c-Jun N-terminal kinase. Sah NK; Munshi A; Kurland JF; McDonnell TJ; Su B; Meyn RE J Biol Chem; 2003 Jun; 278(23):20593-602. PubMed ID: 12663665 [TBL] [Abstract][Full Text] [Related]
4. Synergistic induction of TRAIL-mediated apoptosis by anisomycin in human hepatoma cells via the BH3-only protein Bid and c-Jun/AP-1 signaling pathway. Jin CY; Park C; Hong SH; Han MH; Jeong JW; Xu H; Liu H; Kim GY; Kim WJ; Yoo YH; Choi YH Biomed Pharmacother; 2013 May; 67(4):321-8. PubMed ID: 23582782 [TBL] [Abstract][Full Text] [Related]
5. Sensitization of mesothelioma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by heat stress via the inhibition of the 3-phosphoinositide-dependent kinase 1/Akt pathway. Pespeni MH; Hodnett M; Abayasiriwardana KS; Roux J; Howard M; Broaddus VC; Pittet JF Cancer Res; 2007 Mar; 67(6):2865-71. PubMed ID: 17363610 [TBL] [Abstract][Full Text] [Related]
6. Synergistic induction of cell death in liver tumor cells by TRAIL and chemotherapeutic drugs via the BH3-only proteins Bim and Bid. Schneider-Jakob S; Corazza N; Badmann A; Sidler D; Stuber-Roos R; Keogh A; Frese S; Tschan M; Brunner T Cell Death Dis; 2010 Oct; 1(10):e86. PubMed ID: 21368859 [TBL] [Abstract][Full Text] [Related]
7. c-Jun N-terminal kinase contributes to apoptotic synergy induced by tumor necrosis factor-related apoptosis-inducing ligand plus DNA damage in chemoresistant, p53 inactive mesothelioma cells. Vivo C; Liu W; Broaddus VC J Biol Chem; 2003 Jul; 278(28):25461-7. PubMed ID: 12707267 [TBL] [Abstract][Full Text] [Related]
8. Proteasome inhibitors-mediated TRAIL resensitization and Bik accumulation. Zhu H; Guo W; Zhang L; Wu S; Teraishi F; Davis JJ; Dong F; Fang B Cancer Biol Ther; 2005 Jul; 4(7):781-6. PubMed ID: 16082182 [TBL] [Abstract][Full Text] [Related]
9. MEK1/2 inhibitors potentiate UCN-01 lethality in human multiple myeloma cells through a Bim-dependent mechanism. Pei XY; Dai Y; Tenorio S; Lu J; Harada H; Dent P; Grant S Blood; 2007 Sep; 110(6):2092-101. PubMed ID: 17540843 [TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor-related apoptosis-inducing ligand activates a lysosomal pathway of apoptosis that is regulated by Bcl-2 proteins. Werneburg NW; Guicciardi ME; Bronk SF; Kaufmann SH; Gores GJ J Biol Chem; 2007 Sep; 282(39):28960-28970. PubMed ID: 17686764 [TBL] [Abstract][Full Text] [Related]
11. Bim plays a crucial role in synergistic induction of apoptosis by the histone deacetylase inhibitor SBHA and TRAIL in melanoma cells. Gillespie S; Borrow J; Zhang XD; Hersey P Apoptosis; 2006 Dec; 11(12):2251-65. PubMed ID: 17051334 [TBL] [Abstract][Full Text] [Related]
12. Thiazolide-induced apoptosis in colorectal cancer cells is mediated via the Jun kinase-Bim axis and reveals glutathione-S-transferase P1 as Achilles' heel. Sidler D; Brockmann A; Mueller J; Nachbur U; Corazza N; Renzulli P; Hemphill A; Brunner T Oncogene; 2012 Sep; 31(37):4095-106. PubMed ID: 22158036 [TBL] [Abstract][Full Text] [Related]
13. The proteasome inhibitor MG132 potentiates TRAIL receptor agonist-induced apoptosis by stabilizing tBid and Bik in human head and neck squamous cell carcinoma cells. Sung ES; Park KJ; Choi HJ; Kim CH; Kim YS Exp Cell Res; 2012 Aug; 318(13):1564-76. PubMed ID: 22513214 [TBL] [Abstract][Full Text] [Related]
15. A human scFv antibody against TRAIL receptor 2 induces autophagic cell death in both TRAIL-sensitive and TRAIL-resistant cancer cells. Park KJ; Lee SH; Kim TI; Lee HW; Lee CH; Kim EH; Jang JY; Choi KS; Kwon MH; Kim YS Cancer Res; 2007 Aug; 67(15):7327-34. PubMed ID: 17671202 [TBL] [Abstract][Full Text] [Related]
16. ON-III inhibits erbB-2 tyrosine kinase receptor signal pathway and triggers apoptosis through induction of Bim in breast cancer cells. Li DD; Wu XQ; Tang J; Wei XY; Zhu XF Cancer Biol Ther; 2009 Apr; 8(8):739-43. PubMed ID: 19242112 [TBL] [Abstract][Full Text] [Related]
17. Hedgehog inhibition promotes a switch from Type II to Type I cell death receptor signaling in cancer cells. Kurita S; Mott JL; Cazanave SC; Fingas CD; Guicciardi ME; Bronk SF; Roberts LR; Fernandez-Zapico ME; Gores GJ PLoS One; 2011 Mar; 6(3):e18330. PubMed ID: 21483830 [TBL] [Abstract][Full Text] [Related]
18. FTY720 induces apoptosis of chronic myelogenous leukemia cells via dual activation of BIM and BID and overcomes various types of resistance to tyrosine kinase inhibitors. Kiyota M; Kuroda J; Yamamoto-Sugitani M; Shimura Y; Nakayama R; Nagoshi H; Mizutani S; Chinen Y; Sasaki N; Sakamoto N; Kobayashi T; Matsumoto Y; Horiike S; Taniwaki M Apoptosis; 2013 Nov; 18(11):1437-1446. PubMed ID: 23851982 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of eIF2α dephosphorylation enhances TRAIL-induced apoptosis in hepatoma cells. Teng Y; Gao M; Wang J; Kong Q; Hua H; Luo T; Jiang Y Cell Death Dis; 2014 Feb; 5(2):e1060. PubMed ID: 24525736 [TBL] [Abstract][Full Text] [Related]
20. Bid mediates apoptotic synergy between tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and DNA damage. Broaddus VC; Dansen TB; Abayasiriwardana KS; Wilson SM; Finch AJ; Swigart LB; Hunt AE; Evan GI J Biol Chem; 2005 Apr; 280(13):12486-93. PubMed ID: 15615731 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]